EUVIMEDDescoperă EUVIMED
Open access

Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease

Derek D Satre iD, Dhweeja Dasarathy, Steven L Batki, Michael J Ostacher, Hannah R Snyder, William Hua, Priti Parekh, Amy M Shui, Ramsey Cheung, Alexander Monto, Robert J Wong, Jennifer Y Chen and 6 more

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.18387 ↗

At a glance

Journal article in Alimentary Pharmacology & Therapeutics, 2025. Written by Derek D Satre and 17 co-authors. Institution: Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, California, USA. Major MEDLINE topics: Motivation, Liver Diseases, COVID-19. Cited 2 times so far (Crossref); 48 references. The full text is freely available in PubMed Central. Funded by: NIAAA NIH HHS, NIDDK NIH HHS, The UCSF Dolby Family Center for Mood Disorders.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background and Aims Alcohol use is prevalent among hepatology clinic patients with chronic liver disease (CLD). We explored factors associated with the importance and confidence dimensions of motivation to reduce drinking.

Methods

Participants ( N = 121) with unhealthy alcohol use (i.e., over NIH guidelines) receiving care in hepatology clinics from a safety‐net hospital (SN, N = 54) and two Veterans Affairs Healthcare Systems (VA, N = 67) were enrolled in an alcohol intervention trial from March 2022 through October 2023. Baseline assessments included Generalised Anxiety Disorder (GAD‐7), Patient Health Questionnaire (PHQ‐8), Alcohol Use Disorders Identification Test (AUDIT), COVID‐19 stress; and measures of importance and confidence to decrease alcohol use (readiness rulers, scales of 1–10). Liver disease aetiology and severity were extracted from electronic health records. We performed multivariable linear regression models with forward selection to assess pre‐specified variables' associations with importance and confidence.

Results

The sample was 84% male, 40% Latino, 31% White, 18% Black and 11% other races; median age was 61 years. Median (Q1–Q3) AUDIT score was 16 (12–24), importance was 9 (6–10) and confidence was 8 (5–9). On multivariable analysis, VA site (vs. SN) participants had a 0.97‐point lower importance score ( p = 0.02); higher symptoms of depression (PHQ‐8 score ≥ 10 vs. < 10) and AUDIT scores (for each point increase) were associated with higher importance score (estimates 1.2 and 0.08, p < 0.05, respectively). Liver disease aetiology and severity were not significantly associated with outcomes.

Conclusions

Depression, alcohol problem severity and treatment site may influence motivation to reduce alcohol use and could inform future hepatology‐based interventions.

Subjects

MeSH terms (MEDLINE)

MotivationLiver DiseasesCOVID-19HumansMaleFemaleMiddle AgedAgedAlcohol DrinkingUnited StatesChronic DiseaseAdultAlcoholism

Author keywords

COVID‐19alcoholalcohol‐associated liver diseasecirrhosisdepressionmetabolic dysfunction‐associated steatotic liver diseasemetabolic‐associated steatohepatitis

Authors and institutions

  • Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.
  • Kaiser Permanente Northern California, Division of Research, Pleasanton, California, USA.
  • Vanderbilt School of Medicine, Nashville, Tennessee, USA.
  • Mental Health Service, Veterans Affairs San Francisco Health Care System, San Francisco, California, USA.
  • Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California, USA.
  • Department of Psychiatry, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.

ORCID profiles: Derek D Satre, Mandana Khalili

Funding

  • NIAAA NIH HHS
  • NIDDK NIH HHS
  • The UCSF Dolby Family Center for Mood Disorders
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institute of Diabetes and Digestive and Kidney Diseases

Cite

APA

Satre, D. D., Dasarathy, D., Batki, S. L., Ostacher, M. J., Snyder, H. R., Hua, W., Parekh, P., Shui, A. M., Cheung, R., Monto, A., Wong, R. J., Chen, J. Y., Liao, M., Tana, M., Chen, P. H., Haight, C. G., Fakadej, T., & Khalili, M. (2025). Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18387

Vancouver

Satre DD, Dasarathy D, Batki SL, Ostacher MJ, Snyder HR, Hua W, et al. Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18387

BibTeX
@article{Satre2025,
  author = {Satre, Derek D and Dasarathy, Dhweeja and Batki, Steven L and Ostacher, Michael J and Snyder, Hannah R and Hua, William and Parekh, Priti and Shui, Amy M and Cheung, Ramsey and Monto, Alexander and Wong, Robert J and Chen, Jennifer Y and Liao, Meimei and Tana, Michele and Chen, Po-Hung and Haight, Christina G and Fakadej, Taylor and Khalili, Mandana},
  title = {Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.18387}
}
Start for free →